Screener
Novavax NVAX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Novavax’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income tax expense | 1,711 | 946 | 2,696 | 2,146 |
| Net income (loss) | $(53,387) | $106,508 | $(62,878) | $625,154 |
| Net income (loss) per share: | ||||
| Basic | $(0.32) | $0.66 | $(0.38) | $3.87 |
| Diluted | $(0.32) | $0.62 | $(0.38) | $3.55 |
| Weighted average number of common shares outstanding: | ||||
| Basic | 164,574 | 162,019 | 163,929 | 161,536 |
| Diluted | 164,574 | 177,215 | 163,929 | 177,410 |
Item 1. Consolidated Financial Statements
FAQ
- What is Novavax's shares (diluted)?
- Novavax (NVAX) reported shares (diluted) of 164.6M in Q2 2026.
- How has Novavax's shares (diluted) changed year-over-year?
- Novavax's shares (diluted) decreased by 7.1% year-over-year, from 177.2M to 164.6M.
- What is the long-term trend for Novavax's shares (diluted)?
- Over 4 years (2021 to 2025), Novavax's shares (diluted) has grown at a 23.5% compound annual growth rate (CAGR), from 296.3M to 690.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Novavax's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude